CoChat

Mobile phone use and risk of acoustic neuroma: results of the Interphone case–control study in five North European countries

Open access
Schoemaker, M J, Swerdlow, A J, Ahlbom, A, Auvinen, A, Blaasaas, K G, Cardis, E, Christensen, H Collatz, Feychting, M, Hepworth, S J, Johansen, C, Klæboe, L, Lönn, S, McKinney, P A, Muir, K, Raitanen, J, Salminen, T, Thomsen, J, Tynes, T · 2005 · British Journal of Cancer
Cited by 236

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

There is public concern that use of mobile phones could increase the risk of brain tumours. If such an effect exists, acoustic neuroma would be of particular concern because of the proximity of the acoustic nerve to the handset. We conducted, to a shared protocol, six population-based case-control studies in four Nordic countries and the UK to assess the risk of acoustic neuroma in relation to mobile phone use. Data were collected by personal interview from 678 cases of acoustic neuroma and 3553 controls. The risk of acoustic neuroma in relation to regular mobile phone use in the pooled data set was not raised (odds ratio (OR) = 0.9, 95% confidence interval (CI): 0.7-1.1). There was no association of risk with duration of use, lifetime cumulative hours of use or number of calls, for phone use overall or for analogue or digital phones separately. Risk of a tumour on the same side of the head as reported phone use was raised for use for 10 years or longer (OR = 1.8, 95% CI: 1.1-3.1). The study suggests that there is no substantial risk of acoustic neuroma in the first decade after starting mobile phone use. However, an increase in risk after longer term use or after a longer lag period could not be ruled out.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6602764

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 20

  1. Boice JD, McLaughlin JK (2002) Epidemiologic Studies of Cellular Telephones and Cancer Risk – a Review. Stockholm: Swedish Radiation Protection Authority
  2. Cardis E, Kilkenny M (1999) International case–control study of adult brain, head and neck tumours: results of the feasibility study. Radiat Prot Dosimetry 83: 179–183 · doi:10.1093/oxfordjournals.rpd.a032657
  3. Christensen HC, Schuz J, Kosteljanetz M, Poulsen HS, Thomsen J, Johansen C (2004) Cellular telephone use and risk of acoustic neuroma. Am J Epidemiol 159: 277–283 · DOI · Paper page
  4. Dimbylow P, Mann SJ (1999) Characterisation of energy deposition in the head from cellular phones. Radiat Protect Dosimetry 83: 139–141 · DOI
  5. Hardell L, Mild KH, Carlberg M (2003) Further aspects on cellular and cordless telephones and brain tumours. Int J Oncol 22: 399–407
  6. Hardell L, Nasman A, Pahlson A, Hallquist A, Hansson MK (1999) Use of cellular telephones and the risk for brain tumours: a case–control study. Int J Oncol 15: 113–116
  7. Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine HA, Black PM, Loeffler JS, Linet MS (2001) Cellular-telephone use and brain tumors. N Engl J Med 344: 79–86 · DOI · Paper page
  8. Johansen C, Boice Jr J, McLaughlin J, Olsen J (2001) Cellular telephones and cancer – a nationwide cohort study in Denmark. J Natl Cancer Inst 93: 203–207 · DOI · Paper page
  9. Lahkola A, Salminen T, Auvinen A (2005) Selection bias due to differential participation in a case–control study of mobile phone use and brain tumors. Ann Epidem 15: 321–325 · DOI
  10. Lönn S, Ahlbom A, Hall P, Feychting M (2004) Mobile phone use and the risk of acoustic neuroma. Epidemiology 15: 653–659 · DOI · Paper page
  11. Muscat JE, Malkin MG, Shore RE, Thompson S, Neugut AI, Stellman SD, Bruce J (2002) Handheld cellular telephones and risk of acoustic neuroma. Neurology 58: 1304–1306 · DOI · Paper page
  12. Parslow RC, Hepworth SJ, McKinney PA (2003) Recall of past use of mobile phone handsets. Radiat Prot Dosimetry 106: 233–240 · DOI · Paper page
  13. Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuoka S, Mabuchi K (2002) Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 94: 1555–1563 · DOI · Paper page
  14. Ron E, Modan B, Boice Jr JD, Alfandary E, Stovall M, Chetrit A, Katz L (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319: 1033–1039 · DOI · Paper page
  15. Rothman KJ (2000) Epidemiological evidence on health risks of cellular telephones. Lancet 356: 1837–1840 · DOI
  16. Rothman KJ (2001) Re: Cellular telephones and risk of brain tumours. Lancet 357: 961 · doi:10.1016/s0140-6736(05)71664-0
  17. Rothman KJ, Loughlin JE, Funch DP, Dreyer NA (1996) Overall mortality of cellular telephone customers. Epidemiology 7: 303–305 · DOI
  18. Stukel TA, Demidenko E, Dykes J, Karagas MR (2001) Two-stage methods for the analysis of pooled data. Stat Med 20: 2115–2130 · DOI · Paper page
  19. Thomsen J, Tos M (1990) Acoustic neuroma: clinical aspects, audiovestibular assessment, diagnostic delay, and growth rate. Am J Otol 11: 12–19
  20. Warren HG, Prevatt AA, Daly KA, Antonelli PJ (2003) Cellular telephone use and risk of intratemporal facial nerve tumor. Laryngoscope 113: 663–667 · doi:10.1097/00005537-200304000-00015

Cited by

Metadata

Authors
Schoemaker, M. J., Swerdlow, A. J., Ahlbom, A., Auvinen, A., Blaasaas, K. G., Cardis, E., Christensen, H. C., Feychting, M., Hepworth, S. J., Johansen, C., Klæboe, L., Lönn, S., McKinney, P. A., Muir, K., Raitanen, J., Salminen, T., Thomsen, J., & Tynes, T.
Venue
British Journal of Cancer
Published
2005-08-30
Volume
93
Issue
7
Pages
842-848
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2168756860
Cited by
236
References
1
FWCI
12.95
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.